Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Trial to Evaluate the Efficacy and Safety of Infliximab(Remicade) in Treating Patients With Early Ankylosing Spondylitis

NCT00936143 is registered in ClinicalTrials.gov with Gu Jieruo as lead sponsor.

NCT NCT00936143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00936143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Trial to Evaluate the Efficacy and Safety of Infliximab(Remicade) in Treating Patients With Early Ankylosing Spondylitis
Lead sponsor
Gu Jieruo
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2008
Completion date
December 31, 2009
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spondylitis